Ikonisys S.A. (EPA:ALIKO)

Market Cap	19.63M
Revenue (ttm)	1.01M
Net Income (ttm)	-3.24M
Shares Out	14.02M
EPS (ttm)	-0.29
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,957
Average Volume	3,665
Open	1.410
Previous Close	1.410
Day's Range	1.400 - 1.410
52-Week Range	1.280 - 1.630
Beta	0.70
RSI	37.92
Earnings Date	Apr 29, 2026

About Ikonisys

Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that allows scanning and analysis of cells from a voided urine sample; oncoFI...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2021
• Employees: 15
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALIKO

Financial Performance

In 2024, Ikonisys's revenue was 1.01 million, an increase of 56.72% compared to the previous year's 645,173. Losses were -3.24 million, 42.9% more than in 2023.